Cover Image

Stable human FIX expression after 0.9G intrauterine gene transfer of self-complementary adeno-associated viral vector 5 and 8 in macaques

Intrauterine gene transfer (IUGT) offers ontological advantages including immune naiveté mediating tolerance to the vector and transgenic products, and effecting a cure before development of irreversible pathology. Despite proof-of-principle in rodent models, expression efficacy with a therapeutic...

Full description

Saved in:
Bibliographic Details
Main Authors: Mattar, Citra Nurfarah Zaini (Author) , Nathwani, Amit C (Author) , Waddington, Simon N (Author) , Dighe, Niraja (Author) , Kaeppel, Christine (Author) , Nowrouzi, Ali (Author) , Mcintosh, Jenny (Author) , Johana, Nuryanti B (Author) , Ogden, Bryan (Author) , Fisk, Nicholas M (Author) , Davidoff, Andrew M (Author) , David, Anna (Author) , Peebles, Donald (Author) , Valentine, Marcus B (Author) , Appelt, Jens-Uwe (Author) , Kalle, Christof von (Author) , Schmidt, Manfred (Author) , Biswas, Arijit (Author) , Choolani, Mahesh (Author) , Chan, Jerry KY (Author)
Format: Article (Journal)
Language:English
Published: 2011
In: Molecular therapy
Year: 2011, Volume: 19, Issue: 11, Pages: 1950-1960
ISSN:1525-0024
DOI:10.1038/mt.2011.107
Online Access:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1038/mt.2011.107
Verlag, lizenzpflichtig, Volltext: https://www.sciencedirect.com/science/article/pii/S1525001616327927
Get full text
Author Notes:Citra N.Z. Mattar, Amit C. Nathwani, Simon N. Waddington, Niraja Dighe, Christine Kaeppel, Ali Nowrouzi, Jenny Mcintosh, Nuryanti B. Johana, Bryan Ogden, Nicholas M. Fisk, Andrew M. Davidoff, Anna David, Donald Peebles, Marcus B. Valentine, Jens-Uwe Appelt, Christof von Kalle, Manfred Schmidt, Arijit Biswas, Mahesh Choolani and Jerry K.Y. Chan
Description
Summary:Intrauterine gene transfer (IUGT) offers ontological advantages including immune naiveté mediating tolerance to the vector and transgenic products, and effecting a cure before development of irreversible pathology. Despite proof-of-principle in rodent models, expression efficacy with a therapeutic transgene has yet to be demonstrated in a preclinical nonhuman primate (NHP) model. We aimed to determine the efficacy of human Factor IX (hFIX) expression after adeno-associated-viral (AAV)-mediated IUGT in NHP. We injected 1.0-1.95 × 1013 vector genomes (vg)/kg of self-complementary (sc) AAV5 and 8 with a LP1-driven hFIX transgene intravenously in 0.9G late gestation NHP fetuses, leading to widespread transduction with liver tropism. Liver-specific hFIX expression was stably maintained between 8 and 112% of normal activity in injected offspring followed up for 2-22 months. AAV8 induced higher hFIX expression (P = 0.005) and milder immune response than AAV5. Random hepatocellular integration was found with no hotspots. Transplacental spread led to low-level maternal tissue transduction, without evidence of immunotoxicity or germline transduction in maternal oocytes. A single intravenous injection of scAAV-LP1-hFIXco to NHP fetuses in late-gestation produced sustained clinically-relevant levels of hFIX with liver-specific expression and a non-neutralizing immune response. These data are encouraging for conditions where gene transfer has the potential to avert perinatal death and long-term irreversible sequelae.
Item Description:Elektronische Reproduktion der Druckausgabe
Gesehen am 11.08.2022
Physical Description:Online Resource
ISSN:1525-0024
DOI:10.1038/mt.2011.107

Similar Items